Yayın:
Visceral adipose tissue and body fat mass: Predictive values for and role of gender in cardiometabolic risk among Turks

dc.contributor.authorOnat, Altan
dc.contributor.authorUgur, Murat
dc.contributor.authorCan, Guenay
dc.contributor.authorYuksel, Husniye
dc.contributor.authorHergenc, Guelay
dc.date.accessioned2026-06-27T12:52:46Z
dc.date.issued2010
dc.description.abstractObjective: We investigated the predictive values of visceral adipose tissue area (VAT) and body fat mass for a composite endpoint consisting of type 2 diabetes and coronary heart disease and for incident metabolic syndrome Methods: We analyzed at 4-y follow-up 157 middle-aged men and women in whom body composition analyzer and single-scan computerized tomography had been used Results: Sex- and age-adjusted mean areas of visceral fat were 1 5-fold greater in individuals with than without the composite endpoint (P < 0 001). whereas abdominal subcutaneous fat was similar. Analysis of receiver operating characteristics tor the optimal criterion regarding the composite endpoint (in 37 participants) indicated a VAT of 130 cm(2) and accuracies of 60% in men and 85% in women Whereas age-adjusted VAT alone significantly predicted the composite endpoint in men. body fat mass or VAT predicted it in women (with 2 2- to 2 6-fold relative risks for 1-SD increment). Age-adjusted incident metabolic syndrome was significantly predicted by each parameter in men but only by fat mass in women Conclusion: Visceral adiposity in men and body fat mass in women seem to be of greater relevance in cardiometabolic risk for the prediction of which 130 cm(2) of VAT in both sexes and/or 27 kg of fat mass in women are useful cutoffs Sex differences may reflect the predominating role of visceral adiposity in men and of insulin resistance in women in this risk (C) 2010 Published by Elsevier Incen
dc.description.sponsorshipTurkish Society of Cardiology [2006-2008]
dc.description.sponsorshipSanofiAventis
dc.description.sponsorshipPfizer
dc.description.sponsorshipNovartis
dc.description.sponsorshipAstraZeneca, Istanbul, Turkey
dc.description.urihttps://doi.org/10.1016/j.nut.2009.05.019
dc.identifier.doi10.1016/j.nut.2009.05.019
dc.identifier.eissn1873-1244
dc.identifier.endpage389
dc.identifier.issn0899-9007
dc.identifier.issue4
dc.identifier.pubmed19632090
dc.identifier.startpage382
dc.identifier.urihttps://hdl.handle.net/20.500.14981/47782
dc.identifier.volume26
dc.identifier.wos000277704200006
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofNUTRITION
dc.subjectCoronary heart disease
dc.subjectDiabetes type 2
dc.subjectMetabolic syndrome
dc.subjectObesity
dc.subjectInsulin resistance
dc.subjectVisceral adiposity
dc.subjectABDOMINAL OBESITY
dc.subjectCARDIOVASCULAR-DISEASE
dc.subjectINSULIN-RESISTANCE
dc.subjectOLDER MEN
dc.subjectWOMEN
dc.subjectASSOCIATION
dc.subjectPOPULATION
dc.subjectDEFINITION
dc.subjectHEALTH
dc.subjectNutrition & Dietetics
dc.titleVisceral adipose tissue and body fat mass: Predictive values for and role of gender in cardiometabolic risk among Turks
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar